Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dense weekly paclitaxel in advanced ovarian cancer (JGOG 3016)
NCT00226915Phase 3Completed
- Sponsor
- Japanese Gynecologic Oncology Group
- Start
- Apr 2003
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel in ovarian epithelial cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by Japanese Gynecologic Oncology Group. Started Apr 2003; status: completed.
02
Drugs
paclitaxel
03
Conditions
ovarian epithelial cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT00226915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226915.